In conclusion, we summarized the immunosuppressive effect of EV PD-L1 in many tumor models as well as its potential role as the marker of early cancer diagnosis, tumor progression, and tumor-targeting immunotherapy. The gene discussed is CD274; the disease is neoplasm.